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Abstract 
Recombinant protein A/G (PAG) has a sequence coding for eight IgG binding sites and has enhanced 
inter-species affinity. High-frequency sampling of a PAG titration with IgG produces concentration 
profiles that are sensitive to the kinetic availability of the binding sites. The full kinetic model 
developed here for IgG binding sequentially to PAG shows only two distinct kinetic processes, 
describing an initial rapid association of two antibodies to PAG with a rate constant k-fast = 1.86 ± 0.08 
× 106 M-1 s-1 and a slower antibody binding process to all remaining sites, k-slow = 1.24 ± 0.05 × 104 M-
1 s-1. At equilibrium (after 1 hour), the maximum IgG occupancy of PAG is 2.8 ± 0.5, conflicting with the 
genetic evidence of eight binding sites and suggesting significant steric hindrance of the neighbouring 
IgG binding sites. The phosphate-buffered saline (PBS) solution defines a standard System Setting and 
this may be compared with other settings. The mean association rate of PAG-IgGn in the standard 
setting is 282 ± 20% higher than when PAG is tethered to a surface. A systems biology approach 
requires that a model parameter set that define a system in a Standard Setting should be transferable 
to another system. The transfer of parameters between settings may be performed using activity 
coefficients characterising an effective concentration of species in a system, ai = ici. The activity 
correction,  for the 8-site occupancy is  = 0.35 ± 0.06 and mapping from the standard setting to 
solution setting suggests 𝛾𝑃𝐴𝐺−𝐼𝑔𝐺 = 0.4 ± 0.03. The role of activity coefficients and transferability 
of kinetic parameters between system settings is discussed. 
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Introduction 
Multivalent protein-ligand binding is a fundamental biochemical interaction that is of interest for both 
native proteins in their typical environments as well as modified proteins with tailored applications. 
The genetically-modified protein A/G (PAG) has eight binding sites optimised with high specificity to 
mammalian immunoglobulins by combining the IgG binding domain sequences of Staphylococcal 
protein A (SPA) and Streptococcal protein G (SPG): a model multivalent binding system, PAG-IgGn1 2. 
The PAG-IgGn model is characterised by data from many sources starting with the genetic sequence 
from which there is “genetic evidence” of 8 binding sites with a well-characterised structure and 
affinity for IgG2.  The Fc binding domains of SPA and SPG have been used as a proxy for FcγR receptors 
on the surface of phagocytes3-4 and the binding domain crystal structures have been solved.5-6 PAG  is 
widely used for ligand capture in affinity chromatography7 where there is a tacit assumption that the 
protein activity on a separation surface is the same as in solution and in large excess due to the number 
of binding sites and mass on the surface. However, when purchased, PAG is described as having 6 
binding sites, despite the genetic evidence and there is clearly an unknown fraction of binding sites 
available sterically, Figure 1.  
There is a particularly strong link between genetic modification and kinetic mechanism in the field of 
synthetic multivalent ligand binding in next-generation therapeutic agents and biomaterials.8 The 
architecture of synthetic protein scaffolds may be genetically designed to vary size and valency, which 
control reaction kinetics and mechanism of action.9 Careful quantitative characterisation however, 
requires a suitable sampling frequency to establish kinetically distinct mechanisms from which a set 
of uncoupled kinetic parameters may be derived. The goal of Systems Biology in fields such as 
personalised medicine10 is to combine data from all sources such as in vivo and in vitro  measurements, 
genetic sequence information and surface sensor measurements, to produce a model that is 
predictive in different system settings (healthy and sick patient serum for example). The quantitative 
mechanism must start with the rate of a second order reaction in a model, which is written: 
𝑅𝑎𝑡𝑒 =  𝑘12 [𝑐1][𝑐2] (1)  
where [𝑐1] and [𝑐2] are the reactant concentrations and k12 is the second order rate constant. This 
equation may describe the reaction in a standard system setting such as phosphate-buffered saline 
(PBS). The active or effective concentration of a species available in a different system setting may be 
treated in as the product of the activity coefficient and the measured concentration and is written: 
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𝑎1 =  𝛾1[𝑐1] (2)  
where 1 is the effective activity coefficient of the species 𝑐1. The effective activity of a species depends 
on the difference in the observed system setting (cytoplasm or serum for example), from the standard 
setting in PBS. Significant differences in the effective activity of a species observed in varying system 
settings may fundamentally limit the predictive usefulness of a deterministic model derived from a 
single setting.11 These transferability uncertainties of i capture the difficulty in moving between 
system settings and may go some way to explain observations of enzymes apparently beating the 
diffusion limit for chemical reactions,12 where  𝛾 would be greater than 1.  
The fully predictive kinetic model is burdened by familiar challenges such as measuring data that are 
sensitive to kinetically distinct processes, uncertainties in the determining the global minimum during 
model optimisation and subsequent high correlation between model parameters. Parameters may 
become model-dependent or system-setting dependent and properties such as affinity and avidity 
with unknown steric effects and interface activity13 14 likely differ between system settings. There are 
some notable exceptions such as isothermal calorimetry and stopped-flow fluorescence studies, 
which exemplify a good agreement of solution and interface studies with approximately 5% error15 in 
specific cases. However, system-invariant parameters will need to be established for each new system 
setting individually. Even thorough tests of model parameter purity, starting point invariance and high 
confidence in the global fit solution16 cannot reduce the uncertainty in the activity of proteins and 
variation of kinetic parameters in untested system settings. 
In this paper, we present a series of experiments rapidly sampling the association kinetics of IgG to 
recombinant PAG to detect multiple ligand binding events and use all available evidence to construct 
a fully quantitative kinetic analysis of the of multi-ligand binding interactions.  A deterministic model 
is constructed for 8 binding sites (as indicated by the genetic evidence) from which a set of rate 
constants and activity coefficients are derived in the standard system setting of PBS. Multiple 
parameter search methods are considered to fit the data and dimensionality reduction of the model 
is performed, based on a parameter correlation analysis. The reaction kinetics in the standard system 
setting are compared to those in an alternate system setting where PAG is immobilised on a sensor 
surface, from which further kinetic parameters are derived with activity coefficients. The role of PBS 
as a Standard System Setting, analogous to the standard conditions of thermodynamics, is considered 
together with the transferability of kinetic parameters using the concept of activity coefficients.  
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Materials and Methods 
Pierce recombinant protein A/G (5 mg) was obtained from Thermo Scientific (#21186). IgG antibody 
used was Rabbit anti-Sheep (1 mg/mL) obtained from Bio-Rad (#5184-2304). Human serum albumin 
and bovine serum albumin were obtained from Sigma-Aldrich. Standard instrument running buffer, 
also used in preparation and dilution of the samples, was phosphate-buffered saline (PBS) supplied in 
tablet form by Sigma-Aldrich. Ortho-phosphoric acid (85%) was obtained from Fluka and a 0.1 M 
aqueous solution used as regeneration buffer. GAPSII aminated glass prep slides were obtained from 
Corning (#40006).  
The binding kinetics of IgG binding to surface tethered PAG were determined using a biophotonic 
multiplexed detection platform described in detail elsewhere.17 Briefly, a gold seed nanoparticle array 
is printed with inkjet printer onto a surface and grown into highly sensitive light scatter centres. The 
array is returned to the printer for assay functionalisation with an antigen for specific antibody 
detection, an antibody for antigen detection, or protein A/G for total a total IgG assay. The biophotonic 
array is illuminated in total-internal reflection and scattered light is captured by video camera normal 
to the array surface and at the video-frame rate, to produce the immune-kinetic trace, Figure S1. The 
IgG test array was constructed using 24 assay elements functionalised with PAG printed from a 2 
mg/mL solution in PBS and 50% glycerol; 16 light intensity controls were printed from a 2 mg/mL 
solution of BSA in PBS for reproducibility. The control elements are used to remove the effect of 
refractive index variation with temperature, intensity changes in the lamp illumination and non-
specific protein binding. Nonspecific binding sites on the array surface are blocked with human serum 
albumin (5 μM, 300 seconds) before assay operation.  
Standard solutions of IgG (2.5 nM, 25 nM, 50 nM, 100 nM, 200 nM) are injected over the assay surface 
for a fixed period of 100 seconds to monitor association kinetics to PAG and washed in PBS for 200s 
to monitor dissociation kinetics. Association and dissociation timescales were chosen to provide 
typical errors in estimated association and dissociation rate constants of <15% and <10% respectively,3 
whilst allowing rapid sampling of 5 minutes per sample. The immune-kinetic assay traces, Figure S1, 
are fitted simultaneously for all concentrations to a simple 1:1 Langmuirian adsorption isotherm 
model to produce a global fit.3 The kinetic model of the interface of the sensor surface produces 
average estimates for ka and kd: 3.26±0.03×105 M-1 s-1 and 3.01±0.37×10-4 s-1 respectively, which 
compare favourably with literature values 18.  
The IgG immune-kinetic assay is calibrated using the area-under-the-curve of the association step, 
plotted against IgG concentration and fitted to a 4-parameter logistic (Figure S1) with a resulting R2 of 
0.997. The IgG assay Limit of Detection (3σ of the noise distribution of the PBS blank) is 4.7×10-5 RIU 
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corresponding to 0.4 nM. The Limit of Quantitation, (10σ of the noise distribution of the PBS blank) is 
1.7 nM.  The typical assay error, estimated from 9 sample repeats at 100 nM, is 5 nM (2σ, 95% 
confidence limit). The sampling frequency for the IgG assay is every 5 minutes, allowing for a surface 
regeneration step after each sample measurement, which removes captured IgG in preparation for 
the next sample.  
PAG-IgG reaction mixtures are prepared with PAG mole fractions of: 0.09, 0.14, 0.2, 0.25, 0.3, 0.35, 
0.43 and 0.5. The starting IgG concentration is 100 nM for each mole fraction. The IgG concentration 
in a 500 μL sample of each reaction mixture is measured at 50±30s after mixing and every 5 minutes 
thereafter for 1 hour. 
Results and Discussion 
The effective activity of the recombinant-antibody-binding protein, PAG, was studied quantitatively, 
label-free in solution and modelled using a deterministic ordinary differential equation model fitting 
to the experimental data – a classic systems biology approach. Binary solutions of IgG/PAG were 
prepared with different PAG mole fractions (xPAG) in the range 0 – 0.5 (corresponding to starting 
ratios in the range 1:0 to 1:1 IgG:PAG). The solutions were sampled for unbound IgG within 50 seconds 
of mixing and sampled every 5 minutes for 1 hour, using an immuno-kinetic assay with a limit of 
quantitation of 1.7 nM, Figure 2. From an initial IgG concentration of 100 nM, the antibody 
concentration is seen to fall rapidly within the first 50 seconds followed by further, slower decrease 
over the next hour. The decrease in total IgG in solution after the first 50 seconds is shown in Figure 
2(b) and has a zero asymptote (LoQ 1.7 nM) at mole fractions of PAG in the range 0.35 - 0.43, 
corresponding to 1.6 ± 0.3 IgG molecules bound to PAG. The effective activity of PAG during the initial 
50 seconds of association is the ratio of bound IgG to the genomic maximum of 8 sites2, 𝛾𝑃𝐴𝐺 =
 
1.6 ± 0.3 
8
= 0.20 ± 0.04. The apparent cooperative binding effect observed in Figure 2(b) has been 
previously reported for SPA19 and may be explained by fewer antibodies bridging two PAG proteins by 
binding to two sites at higher mole fractions of antibody.20  
The number of bound IgG per individual PAG after 1 hour, Figure 3, is 2.8 ± 0.5, markedly similar to 
the literature values for SPA (2.5 - 3.1) 21 and corresponding to a 𝛾𝑃𝐴𝐺 = 
2.8 ± 0.5
8
= 0.35 ± 0.06. The 
stoichiometry of PAG-IgG binding interaction after 1 hour is significantly below the 8 binding sites 
suggested by the sequence2 or the 6 binding sites as sold by many suppliers. The steric blocking of 
neighbouring IgG binding sites on the genetically modified PAG appears to be no better than for native 
SPA. Despite reports that the sum of weaker contacts in a flexible context around a central scaffold 
can be more efficient than precise design and strong individual interactions22, steric hindrance 
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between binding domains must be considered in ligand design. Future synthetic Fc binding proteins 
should include contacts around platforms with considered geometries able to better accommodate 
IgG in all binding sites. 
An ordinary differential equation (ODE) model is presented here for the sequential filling of 8 binding 
sites (the number suggested by the genetics literature) on the PAG molecule assuming sequential non-
cooperative binding. The model is described by molecular equations 1a-8a and mathematically by 
differential equations 1b-8b with ka and kd representing the forward and reverse reaction rate 
constants respectively. All effective activity coefficients are assumed to be 1.  
𝐼𝑔𝐺 + 𝑃𝐴𝐺
𝑘𝑎1
→  
𝑘𝑑1
←  
 𝐼𝑔𝐺1𝑃𝐴𝐺 
(1a) 𝑑[𝐼𝑔𝐺]
𝑑𝑡
= 𝑘𝑑1[𝐼𝑔𝐺1𝑃𝐴𝐺] − 𝑘𝑎1[𝐼𝑔𝐺][𝑃𝐴𝐺] 
(1b) 
𝐼𝑔𝐺 + 𝐼𝑔𝐺1𝑃𝐴𝐺
𝑘𝑎2
→  
𝑘𝑑2
←  
𝐼𝑔𝐺2𝑃𝐴𝐺 
(2a) 𝑑[𝐼𝑔𝐺]
𝑑𝑡
= 𝑘𝑑2[𝐼𝑔𝐺2𝑃𝐴𝐺] − 𝑘𝑎2[𝐼𝑔𝐺][𝐼𝑔𝐺1𝑃𝐴𝐺] 
(2b) 
𝐼𝑔𝐺 + 𝐼𝑔𝐺2𝑃𝐴𝐺
𝑘𝑎3
→  
𝑘𝑑3
←  
𝐼𝑔𝐺3𝑃𝐴𝐺 
(3a) 𝑑[𝐼𝑔𝐺]
𝑑𝑡
= 𝑘𝑑3[𝐼𝑔𝐺3𝑃𝐴𝐺] − 𝑘𝑎3[𝐼𝑔𝐺][𝐼𝑔𝐺2𝑃𝐴𝐺] 
(3b) 
𝐼𝑔𝐺 + 𝐼𝑔𝐺3𝑃𝐴𝐺
𝑘𝑎4
→  
𝑘𝑑4
←  
𝐼𝑔𝐺4𝑃𝐴𝐺 
(4a) 𝑑[𝐼𝑔𝐺]
𝑑𝑡
= 𝑘𝑑4[𝐼𝑔𝐺4𝑃𝐴𝐺] − 𝑘𝑎4[𝐼𝑔𝐺][𝐼𝑔𝐺3𝑃𝐴𝐺] 
(4b) 
𝐼𝑔𝐺 + 𝐼𝑔𝐺4𝑃𝐴𝐺
𝑘𝑎5
→  
𝑘𝑑5
←  
𝐼𝑔𝐺5𝑃𝐴𝐺 
(5a) 𝑑[𝐼𝑔𝐺]
𝑑𝑡
= 𝑘𝑑5[𝐼𝑔𝐺5𝑃𝐴𝐺] − 𝑘𝑎5[𝐼𝑔𝐺][𝐼𝑔𝐺4𝑃𝐴𝐺] 
(5b) 
𝐼𝑔𝐺 + 𝐼𝑔𝐺5𝑃𝐴𝐺
𝑘𝑎6
→  
𝑘𝑑6
←  
𝐼𝑔𝐺6𝑃𝐴𝐺 
(6a) 𝑑[𝐼𝑔𝐺]
𝑑𝑡
= 𝑘𝑑6[𝐼𝑔𝐺6𝑃𝐴𝐺] − 𝑘𝑎6[𝐼𝑔𝐺][𝐼𝑔𝐺5𝑃𝐴𝐺] 
(6b) 
𝐼𝑔𝐺 + 𝐼𝑔𝐺6𝑃𝐴𝐺
𝑘𝑎7
→  
𝑘𝑑7
←  
𝐼𝑔𝐺7𝑃𝐴𝐺 
(7a) 𝑑[𝐼𝑔𝐺]
𝑑𝑡
= 𝑘𝑑7[𝐼𝑔𝐺7𝑃𝐴𝐺] − 𝑘𝑎7[𝐼𝑔𝐺][𝐼𝑔𝐺6𝑃𝐴𝐺] 
(7b) 
𝐼𝑔𝐺 + 𝐼𝑔𝐺7𝑃𝐴𝐺
𝑘𝑎8
→  
𝑘𝑑8
←  
𝐼𝑔𝐺8𝑃𝐴𝐺 
(8a) 𝑑[𝐼𝑔𝐺]
𝑑𝑡
= 𝑘𝑑8[𝐼𝑔𝐺8𝑃𝐴𝐺] − 𝑘𝑎8[𝐼𝑔𝐺][𝐼𝑔𝐺7𝑃𝐴𝐺] 
(8b) 
The ODE solutions are propagated numerically (Runge-Kutta) and fitted simultaneously to all of the 
data in Figure 2, with equal weighting, using a non-linear least squares trust region reflective method23-
24. All data processing is performed off-line using a commercial software package (MATLAB R2016a). 
The initial guess values for the association and dissociation rate constants of the fitting routine are 
taken from the interface biosensor study, fitting all of the association and dissociation traces, Figure 
S1, simultaneously. The model fit does not converge when all 16 rate constants are allowed to change, 
owing to the high correlations between the parameters and multiply degenerate solutions for all 
positions in parameter space.  
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The first parameter reduction technique is to fix the PAG-IgG dissociation rate at the rate observed on 
the surface. The dissociation rate or complex half-life reflects how well bound the IgG is to the PAG 
which is least likely to vary between settings. There is little opportunity for surface avidity for the Fc 
region binding and constant complex half-life is a reasonable assumption. The dissociation rates for 
all PAG-IgGn complexes are set at 3.01 × 10-4 s-1 and the association rates of all reactions are fitted to 
the data. The 8 association rate constants are determined with poor confidence (Table S1) and remain 
highly correlated; the correlation matrix can be seen graphically in Figure 4 and numerically in Table 
S2. The heat map of the correlation matrix, Figure 4a shows a striking division into two parameter 
regimes and the correlation graph in figure 4b shows the connectivity of the rate constants. The 
parameters in the model may be grouped based on the correlation connectivity into a single fast 
association reaction, combining ka1 - ka2, and ka3-ka8 into a single slow-kinetic association, allowing the 
fit to converge with good root-mean-square-error (RMSE), improved parameter confidence and 
reduced parameter correlation,  
Table 1.  
The 8-binding site ODE model may also be reduced to sequential filling of 3 binding sites only (the 
number determined experimentally by titration, Figure 3) using the same parameter grouping as the 
8-site model (k-fast = ka1-2 and k-slow = ka3). The RMSE for the 8 site and 3 site models are not 
significantly different; 3.25 nM and 3.31 nM respectively. Considering both goodness-of-fit and 
titration data, the reaction mechanism in solution is best described by 3 antibody binding steps, rather 
than 8 as predicted by the genetic evidence. The correlation coefficient between k-fast and k-slow, is 
-0.030 and -0.052 for both models respectively, indicating that the k-fast and k-slow parameter groups 
are kinetically distinct in the data.  
There are two observations with consequences for spin-column separation science: the surface excess 
of binding sites for PAG on the surface may be significantly lower than expected and loading times for 
the column may be as short as 50 seconds rather than 10 minutes as indicated in some protocols. Both 
binding site models have the same fitted k-fast rate constant and predict that after 50 seconds, 
unbound IgG concentration is reduced by 50% and 99% at PAG mole fractions of 0.20 and 0.43 
respectively (Figure 2). The antibody titration shows that ka1-2 dominate the reaction in early time 
and complete antibody binding may be achieved rapidly with sufficient excess of PAG of antibody. 
Over-loading of the column is probably the major concern if reliance on 6-fold binding site excess (as 
sold) or 8-fold as indicted genetically were critical in the adoption or modification of a protocol.  
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Two systems settings may now be compared with the activity formalism: solution and interface. The 
association rate of the IgG-PAG reaction differs significantly between solution and surface tethered 
PAG ( 
Table 1). The fitted 8-site and 3-site models have mean association rate constants that are 47 ± 8 % 
and 282 ± 20 % greater than ka derived from biosensor data of the IgG association to tethered PAG at 
a plasmon surface (3.26 ± 0.03 ×105 M-1 s-1).  The difference between the interface and solution-phase 
reaction rates may be attributed to several factors including differences in diffusion coefficients 
(limiting rate constants), reduced effective activity at the interface and limited transport across any 
interface that forms between the tethered proteins and the bulk solution. However, there is also a 
clear steric effect with the acceptance angle of the surface collision (Figure 1)  likely limited to a solid 
angle of ~2 steradians with consequences for surface packing20, enhanced co-operative binding19 and 
potentially different surface complexes including surface avidity25 and bridging. These latter effects 
are apparent as departures from the 1:1 surface binding model that are visible in the multi-
concentration global fit to the 1:1 binding kinetics (Figure S1). All these effects can be grouped into 
‘effective activity’ that would show concentration dependence, leaving a “pure” transferable rate 
constant that could be determined under conditions of low surface protein density and low solution 
IgG concentrations to provide a best estimate of the limiting value for the rate constant and hence the 
thermodynamics of the complex stability.  
The k-fast and k-slow rate constants reduction demonstrates a persistent challenge for systems 
biology and more generally kinetics. Kinetically distinct processes in a deterministic model must have 
significantly different rates to be determined experimentally, highlighting that kinetic data need to be 
recorded at a sufficiently rapid sampling rate. Similar fast or slow kinetic processes may never be 
distinguishable. Secondly, even with high quality data, there must be a global minimum in the fitted 
model if the kinetic parameters are to decouple sufficiently to allow the model to be predictive. The 
k-fast-k-slow parameter space in the current model can be explored in a box search and plotted in 3D 
with RMSE as the figure of merit of the fit, Figure 5. The parameter space exploration allows the depth 
of the global minimum from the starting point is 27.0 – 3.46 nM (RMSE) for the 8-site model and 12.6 
– 3.31 nM (RMSE) for the 3-site model. Critically, two fitting routines, least squares and a pattern 
search method26, find the same minimum and show good starting-point invariance. Starting point 
invariance is a good test of model accuracy but is rarely checked so easily. There can be reasonable 
certainty in the purity of the two grouped rate constants k-fast and k-slow and that their resolution 
into kinetically distinct process is constrained by the lack of data in the first 50 seconds. Hence with 
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some confidence, the PAG-IgG1-3 interaction is accurately described by two processes: an initial rapid 
binding of two IgG ligands followed more slowly by at most one further IgG.  
The concept of a standard setting must be considered. For protein-protein interactions the standard 
setting must capture the fundamental kinetics and thermodynamics of the interaction minimising the 
effects of concentration perturbations such as hydrodynamic effects in the crowded environments of 
cell cytoplasm27. The rate constants determined in the standard setting provide the best 
understanding of association, dissociation and affinity of the ligand-protein interaction and define the 
standard number of binding sites. PAG-IgG does not have 8-sites as predicted by the genetic sequence. 
In the cytoplasm, as much as 40% of the total volume may be occupied by proteins, and crowding 
effects will generate several perturbations to protein-protein interactions and ligand binding. Reduced 
diffusion rate also changes the collision number within the environment. Interactions may be sterically 
favoured or hindered and concentrations of reactants may be enhanced or depleted by association 
with different components. The description of the second order reaction in equation (1) with the 
activity, i, in equation (2) captures the variations between the simple system settings observed. One 
approach is to fix the concentration and reaction rate constant at the standard system setting, PBS, 
which captures the kinetics and thermodynamics of the ligand-binding site interactions and introduce 
an activity coefficient, i, that needs to be well defined for the standard setting. In this study, the 
number of kinetically active sites, 𝛾𝑃𝐴𝐺 = 
2.8 ± 0.5
8
= 0.35 ± 0.06, defines an effective activity for the 
PAG in PBS. Parameter transfer between system settings requires the contributing factors to be 
identified and trends in increasing molecular crowding to be understood or measured empirically. 
 
Conclusions 
The transferability of parameters from one set of fitted data to any new system setting is required if 
a systems biology model is to be usefully predictive. A clear starting point of a standard setting in PBS 
is capturing the kinetics and thermodynamics of the protein-ligand binding interactions in standard 
conditions. Transition to other system settings modifies the protein concentrations with an activity 
coefficient, 1, and fundamentally the interactions themselves but identifies considerable variations.  
The binding capacity of the PAG-IgG interaction is a maximum of 2.8 ± 0.5 IgG in solution despite 
genomic evidence suggesting the availability of 8 binding sites. The activity coefficient for binding is 
𝛾𝑃𝐴𝐺 = 0.35 ± 0.06. Similarly, interface and solution rate parameters for the PAG-IgG ligand binding 
interaction are observed to be significantly different and consequently PAG-IgG activity at the 
interface may be defined as 𝛾𝑃𝐴𝐺−𝐼𝑔𝐺 = 0.40 ± 0.03, based on the estimates of the rate constants 
11 
 
of the 3-binding site model in solution. The different contributions from 𝛾𝑃𝐴𝐺  and 𝛾𝐼𝑔𝐺 to the standard 
system binding model presented here are unknown and understanding the product of effective 
activity and rate constants may be a fundamental uncertainty of systems biology. Hence models of 
the immune system for instance may change for a healthy patient to a sick patient where the patient’s 
response changes the viscosity and protein composition of the serum. Amplification of transferability 
uncertainties through a larger reaction networks in a more complex system would likely lead to a loss 
of any model predictability. Model parameters derived from genomics or from alternate systems 
settings should be used with caution when developing systems biology models and may not be 
transferrable. 
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Figures and Tables 
 
Figure 1 Protein A/G (purple) binding to IgG (green). Each bound IgG will occupy a fraction of the available 
spherical surface area (yellow) and must reduce the solid angle available to further IgG molecules.  
 
 
 
Figure 2 Time course analysis of IgG binding to solution phase recombinant protein A/G. a) Unbound IgG 
concentration is shown for varying ratios of antibody and PAG: control, 10:1, 6:1, 3:1, 1:1. Error bars are 
±2σ typical assay error, 5nM. The data are fit to a kinetically distinct 3-binding site model (solid blue) and 
an 8-binding site model (dashed red). b) Titration of the free IgG against the mole fraction of Protein A/G, 
sampled at the end of the first kinetic process 50±30 seconds after mixing. Error bars are ±2σ typical assay 
error, 5nM. A 3-site model (solid blue) and an 8-site model (dashed red) are overlaid. 
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Figure 3 Effective stoichiometry of antibody (IgG) bound per protein A/G binding at varying mole fractions 
of protein A/G. Data are derived from the mean of triplicate IgG samples at 55 minutes ±5 minutes after 
mixing with protein A/G; error bars are ±2σ. A 3-binding site model (solid blue) and an 8-binding site model 
(dashed red) are overlaid. 
 
 
 
 
Figure 4 Parameter correlation for the 8 binding site, 8-parameter fit of the association rate constant 
parameters only. The initial guess values for the association rate constants of the fitting routine were 
taken from the interface biosensor study. a) Heat map of the correlation matrix, b) Node map of absolute 
pairwise parameter correlation, showing two distinct groups of parameters. Every model parameter is 
represented by a node and is linked to another parameter node if their absolute pairwise correlation is 
greater than 0.2. The figure highlights the rationale for grouping k1-2 into k-fast and k3-8 into k-slow. 
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Figure 5 Box-search parameter space of root mean square error at various combinations of k-fast and k-
slow for the 3-binding site fit. The global minimum estimated by pattern search (green sphere) is within 
95% confidence limits of the least squares fit result (red sphere). The least squares fit search path (red 
dashed line) and pattern search points (black crosses) originate from k-fast and k-slow initial guesses set 
at the surface studies value of 3.26×105 (outside plot range). 
 
 
 
 
 
 
 
 
Fit Property Biosensor 
Interface Value 
Least squares local 
minimum estimate 
Pattern search global 
minimum estimate 
8 binding 
site model 
k-fast / M-1 s-1 3.26 × 105 1.90 ± 0.09 × 106 1.89 × 106 
k-slow / M-1 s-1 3.26 × 105 6.10 ± 0.01 × 103 6.10 × 103 
kd / s-1 3.01 × 10-4 - - 
RMSE / nM 27.0 3.46 3.46 
3 binding 
site model 
k-fast / M-1 s-1 3.26 × 105 1.86 ± 0.08 × 106 1.85 × 106 
k-slow / M-1 s-1 3.26 × 105 1.24 ± 0.05 × 104 1.24 × 104 
kd / s-1 3.01 × 10-4 - - 
RMSE / nM 12.6 3.31 3.31 
 
Table 1 Results of fitting 8 and 3 binding site models to IgG-PAG binding time course data  
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